Capital Rotation: Latest Moves on NXP, nVent and 8 Second-Tier Plays

I'm told that as the current earnings season matures, institutional capital is quietly rotating into a diverse basket of second-tier plays—from AI infrastructure enablers to specialized healthcare platforms. Behind the scenes, several major funds have significantly ramped up their exposure to semiconductor and liquid cooling names in recent weeks, marking what could be the most significant portfolio overhaul in this segment since early last year.

NXP Semiconductors (NXPI.US)

NXP Semiconductors (NXPI.US) has rallied significantly this year, outpacing many of its legacy chipmaking peers. The company delivered $3.5 billion in Q2 2026 revenue, up 19% year-over-year. According to people familiar with the matter, demand for its physical AI and software-defined vehicle processors is seeing an unprecedented surge. Internally, executives are confident that the semiconductor inventory correction is officially over, pivoting their full focus toward higher-margin automotive tech before the next earnings.

nVent Electric (NVT.US)

nVent Electric (NVT.US) is making aggressive moves in data center infrastructure, helping its shares outperform the broader market recently. After hitting a $1.2 billion sales record in Q1 2026, I'm told the company is leaning heavily into its partnership with NVIDIA. They are racing to deploy massive modular liquid cooling solutions for hyperscalers, fundamentally repositioning the firm from a traditional electrical supplier to a critical engineering backbone for AI clusters.

FactSet Research Systems (FDS.US)

FactSet (FDS.US) continues to consolidate its grip on the financial data space, keeping its stock action steady this month. With Q3 fiscal 2026 revenue climbing to $622.9 million, sources say the firm's $246.5 million buyout of LiquidityBook is part of a larger strategic blueprint. The goal is to integrate its new Google Cloud-partnered, Gemini-powered AI tools deep into front-office trading workflows, aggressively taking on rival terminal dominance.

So-Young International (SY.US)

So-Young International (SY.US) saw a noticeable rebound following its latest quarterly results. The Chinese medical aesthetics platform reported a 33.4% jump in Q2 2026 revenue, reaching 505.2 million RMB. I'm hearing that its aggressive offline expansion—now operating 65 youth clinics across 18 cities—is the primary engine driving its massive 129.5% surge in medical aesthetic service revenues.

Also

• AEVEX Corp. (AVEX.US): The defense tech contractor maintains a robust $432 million annual revenue base and recently secured a pivotal $41 million US government award for autonomous one-way attack systems.
• CVR Energy (CVR.US): Rebounded to a $46 million net income in Q2 2026. The firm is actively advancing a $136 million project to expand premium gasoline capacity in Oklahoma.
• Valvoline (VVV.US): Generated $1.76 billion in FY 2025 revenue. Management is now quietly piloting a mobile on-site vehicle maintenance service to disrupt the traditional auto aftermarket.
• Senseonics Holdings (SENS.US): Delivered a 118% revenue jump in Q2 2026, capitalizing heavily on the landmark FDA approval of its 365-day Eversense CGM system.
• Coca-Cola Consolidated (COKE.US): Achieved $2.05 billion in Q2 2026 sales, though executives are increasingly frustrated as rising aluminum costs remain a persistent drag on operating margins.
• Palladyne AI Warrants (PDYNW.US): The AI-software-turned-defense-contractor projects up to $27 million in 2026 revenue, driving unusual market activity in its publicly traded warrants.

This article does not constitute investment advice.